Central Serous Chorioretinopathy/Pachychoroid Eye Diseases
Author:
Lee Jae Hyung,Lee Won Ki
Publisher
Springer Singapore
Reference64 articles.
1. Artunay O, Yuzbasioglu E, Rasier R, et al. Intravitreal bevacizumab in treatment of idiopathic persistent central serous chorioretinopathy: a prospective, controlled clinical study. Curr Eye Res. 2010;35:91–8.
2. Bae SH, Heo J, Kim C, et al. Low-fluence photodynamic therapy versus ranibizumab for chronic central serous chorioretinopathy: one-year results of a randomized trial. Ophthalmology. 2014;121:558–65.
3. Balaratnasingam C, Lee WK, Koizumi H, et al. Polypoidal choroidal vasculopathy: a distinct disease or manifestation of many? Retina. 2016;36:1–8.
4. Barteselli G, Chhablani J, El-Emam S, et al. Choroidal volume variations with age, axial length, and sex in healthy subjects: a three-dimensional analysis. Ophthalmology. 2012;119:2572–8.
5. Bastl CP. Regulation of cation transport by low doses of glucocorticoids in in vivo adrenalectomized rat colon. J Clin Invest. 1987;80:348–56.